Winthrop Advisory Group LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1739043
BOSTON, MA
Position in REGN
as of Mar 31, 2026
· filed Apr 13, 2026
Position Value
$210,930
-$88,673 QoQ
Shares Held
273
-4.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Winthrop Advisory Group LLC holds $295,057 across 1 Biotechnology name.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
594 | $295,057 |
All Filings in REGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $210,930 | 273 | Shares | Sole | 2026-04-13 | |
| 2024-09-30 | $299,603 | 285 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $301,645 | 287 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $283,934 | 295 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $263,487 | 300 | Shares | Sole | 2024-01-10 | |
| No filing history on record for this holder in this stock. | ||||||